Stock Track | JD HEALTH Soars 6.01% Intraday as CICC Raises Revenue and Profit Forecasts

Stock Track01-06

JD HEALTH's stock surged 6.01% intraday following a bullish research report from CICC. The firm raised its revenue forecasts for 2025 and 2026 by 2% to RMB 72.5 billion and RMB 81.7 billion, respectively, and increased non-IFRS net profit forecasts by 4% and 1% for the same periods. CICC maintained its Outperform rating and target price of HK$71.4, citing strong business performance and strategic partnerships.

The report highlighted JD HEALTH's robust revenue growth, with each of the first three quarters of 2025 achieving approximately 25% year-on-year growth. Strategic collaborations with pharmaceutical giants like Eli Lilly and Bayer China further strengthened its position as a leading online platform for new drugs. Improved gross margins and controlled expense investments also contributed to the positive outlook.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1132328654?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-06 09:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1132328654","market":"nz","top_or_hot":-1,"title":"Stock Track | JD HEALTH Soars 6.01% Intraday as CICC Raises Revenue and Profit Forecasts","media":"Stock Track","content":"<p>JD HEALTH's stock surged 6.01% intraday following a bullish research report from CICC. The firm raised its revenue forecasts for 2025 and 2026 by 2% to RMB 72.5 billion and RMB 81.7 billion, respectively, and increased non-IFRS net profit forecasts by 4% and 1% for the same periods. CICC maintained its Outperform rating and target price of HK$71.4, citing strong business performance and strategic partnerships.</p><p>The report highlighted JD HEALTH's robust revenue growth, with each of the first three quarters of 2025 achieving approximately 25% year-on-year growth. Strategic collaborations with pharmaceutical giants like Eli Lilly and Bayer China further strengthened its position as a leading online platform for new drugs. Improved gross margins and controlled expense investments also contributed to the positive outlook.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | JD HEALTH Soars 6.01% Intraday as CICC Raises Revenue and Profit Forecasts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | JD HEALTH Soars 6.01% Intraday as CICC Raises Revenue and Profit Forecasts\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-01-06 09:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>JD HEALTH's stock surged 6.01% intraday following a bullish research report from CICC. The firm raised its revenue forecasts for 2025 and 2026 by 2% to RMB 72.5 billion and RMB 81.7 billion, respectively, and increased non-IFRS net profit forecasts by 4% and 1% for the same periods. CICC maintained its Outperform rating and target price of HK$71.4, citing strong business performance and strategic partnerships.</p><p>The report highlighted JD HEALTH's robust revenue growth, with each of the first three quarters of 2025 achieving approximately 25% year-on-year growth. Strategic collaborations with pharmaceutical giants like Eli Lilly and Bayer China further strengthened its position as a leading online platform for new drugs. Improved gross margins and controlled expense investments also contributed to the positive outlook.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06618","symbol_name":"京东健康","start_time":0,"source_url":"","article_id":"1132328654","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1132328654","pubTimestamp":1767663646,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"JD HEALTH's stock surged 6.01% intraday following a bullish research report from CICC. The firm raised its revenue forecasts for 2025 and 2026 by 2% to RMB 72.5 billion and RMB 81.7 billion,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06618":"京东健康"},"translate_title":"个股赛道|京东健康盘中大涨6.01%中金上调营收盈利预期","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06618":1},"content_text":"JD HEALTH's stock surged 6.01% intraday following a bullish research report from CICC. The firm raised its revenue forecasts for 2025 and 2026 by 2% to RMB 72.5 billion and RMB 81.7 billion, respectively, and increased non-IFRS net profit forecasts by 4% and 1% for the same periods. CICC maintained its Outperform rating and target price of HK$71.4, citing strong business performance and strategic partnerships.The report highlighted JD HEALTH's robust revenue growth, with each of the first three quarters of 2025 achieving approximately 25% year-on-year growth. Strategic collaborations with pharmaceutical giants like Eli Lilly and Bayer China further strengthened its position as a leading online platform for new drugs. Improved gross margins and controlled expense investments also contributed to the positive outlook.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1132328654","isCrawlerRequest":true}